| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/16/1992 | CA2092924A1 Gro genes, proteins, and uses thereof |
| 04/15/1992 | EP0480381A1 Endothelin receptors |
| 04/15/1992 | EP0479910A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp-Phe- AND PHENETHYLAMINE DERIVATIVES |
| 04/14/1992 | US5104641 Nitroxide NMR contrast enhancing agents and their use in NMR imaging |
| 04/13/1992 | CA2050046A1 Peptide and diagnostic for diseases with abnormal thyroid functions comprising the same |
| 04/09/1992 | CA2053017A1 Endothelin receptors |
| 04/07/1992 | US5102990 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 04/07/1992 | US5102653 Measurment of sensitivity using rabbit eyes |
| 04/07/1992 | US5102652 Biodegradable coated paramagnetic colloids and mannitol; storage stability; treating anemia |
| 04/07/1992 | US5101827 Lymphographic and organ imaging method and kit |
| 04/06/1992 | WO1992005806A1 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography |
| 04/03/1992 | WO1992005866A2 Efficient microcapsule preparation and method of use |
| 04/03/1992 | CA2092551A1 Efficient microcapsule preparation and method of use |
| 04/02/1992 | WO1992004916A2 Particulate agents |
| 04/01/1992 | EP0262123B1 New compositions usable in tomo-densitometry |
| 03/31/1992 | US5100646 NMR glomerular filtration test |
| 03/28/1992 | WO1992005804A1 Chelating agents |
| 03/28/1992 | CA2092434A1 Chelating agents |
| 03/25/1992 | EP0476015A1 Recombinant alzheimer's amyloid protein |
| 03/25/1992 | EP0476011A1 Photosensitizing diels-alder porphyrin derivatives |
| 03/25/1992 | CN1059659A Diagnosis and treatment of viral hepatitis |
| 03/24/1992 | US5099004 Antibodies such as monoclonal antibodies |
| 03/24/1992 | US5099000 Fluorescent compounds for immunoassay as tracers |
| 03/24/1992 | US5098692 Gadolium complexes with N6-carboxymethyl-N3,N9-bis(methyl carbamoyl-methyl)-3,6,9-triazaundecanedioic acid and complexes with calcium |
| 03/24/1992 | US5098691 A cobalamin compound such as vitamin B12 as the marking agent |
| 03/19/1992 | WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/19/1992 | WO1992004392A1 Polymers containing diester units |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/18/1992 | EP0474785A1 Percutaneous lymphography |
| 03/18/1992 | EP0183760B1 Nmr contrast agents |
| 03/17/1992 | US5096694 Compounds which are useful, in particular, for radiotherapy or imaging of cancer |
| 03/14/1992 | WO1992004919A1 Novel magnetic resonance imaging agents |
| 03/14/1992 | CA2068424A1 Magnetic resonance imaging agents |
| 03/11/1992 | EP0473729A1 Contrast media |
| 03/10/1992 | US5095097 Diagnostics |
| 03/05/1992 | WO1992004463A1 Cd58-specific monoclonal antibodies and their use |
| 03/05/1992 | WO1992003428A1 Perfluoro-4,4'-bis(2,2-dimethyl-1,3-dioxolane) and its preparation and use |
| 03/05/1992 | WO1992003168A1 New use of complex salts |
| 03/05/1992 | CA2081770A1 A cd58-specific monoclonal antibody and the use thereof |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0472522A1 Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics. |
| 03/04/1992 | EP0328542B1 Antiparathyroid antibody preparation |
| 03/03/1992 | US5093106 Method for contrasting malignant neoplasms using fluorescein and a sugar |
| 03/03/1992 | US5093042 Site-specific for liver; diagnosis of metastatic cancer |
| 03/03/1992 | CA1296715C 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecane and analogs |
| 02/26/1992 | EP0471792A1 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 02/26/1992 | EP0471790A1 Method for localization and treatment of tumors and complexes therefor |
| 02/26/1992 | CN1058959A Oligomers, their uses and formulations |
| 02/25/1992 | US5091169 Water soluble, stable chelates with paramagnetic metal ions |
| 02/22/1992 | WO1992003380A1 Method for making uniformly-sized particles from insoluble compounds |
| 02/22/1992 | CA2089075A1 Method for making uniformly-sized particles from insoluble compounds |
| 02/20/1992 | WO1992002940A1 Method for producing magnetic microparticles from metallocenes |
| 02/20/1992 | WO1992002560A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/20/1992 | WO1992002527A1 New carbohydrate-based anti-inflammatory agents |
| 02/20/1992 | WO1992002259A1 Novel compositions for magnetic resonance imaging |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991012824A3 19f labelled compounds as nmr imaging and spectroscopy agents |
| 02/20/1992 | DE4026103A1 Manganese complexes for nmr imaging of pancreas - contain the ligand n,n'-bis-(pyridoxal-5-phosphate) ethylene di:amine n.n'-di:acetic acid |
| 02/20/1992 | CA2088923A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/20/1992 | CA2088489A1 Carbohydrate-based anti-inflammatory agents |
| 02/18/1992 | US5089644 Preparation of oxamine complexes |
| 02/18/1992 | US5089479 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| 02/18/1992 | US5089472 Administering for short term memory or attention |
| 02/18/1992 | US5088499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 02/11/1992 | US5087696 Conjugate compound |
| 02/11/1992 | US5087636 Method to destroy malignant cells in mononuclear cell populations |
| 02/11/1992 | US5087440 Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
| 02/11/1992 | US5087439 Paramagnetic metal-diethylenetriamine-pentaacetic acid partial amide complexes for magnetic resonance imaging |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/06/1992 | WO1992001478A1 Diagnostic compositions for assessment of pancreatic insufficiency |
| 02/05/1992 | EP0469632A1 Modulated xenogeneic organ systems in a immunocompromised host |
| 02/04/1992 | CA2048406A1 Modulated xenogeneic organ systems in an immunocompromised host |
| 02/04/1992 | CA1295237C Method for enhancing the safety of metal-ligand chelates as magnetic resonanis imaging agents and x-ray contrast agents |
| 01/29/1992 | EP0468634A1 The use of macrocyclic aminophosphonic acid complexes as imaging agents |
| 01/29/1992 | EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
| 01/29/1992 | EP0467954A1 Preparation of liposome and lipid complex compositions. |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | EP0467885A1 NATIVE-STATE METHOD AND SYSTEM FOR DETERMINING VIABILITY AND PROLIFERATIVE CAPACITY OF TISSUES $i(IN VITRO) |
| 01/28/1992 | WO1992002634A1 ASSAY, METHODS AND PRODUCTS BASED ON n K+ CHANNEL EXPRESSION |
| 01/28/1992 | US5084382 A color former with an oxidizable coupler for detection of hydrogen peroxide or hydrogen peroxide forming system or peroxidase or oxidizers for amine detection |
| 01/28/1992 | US5084266 Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody |
| 01/28/1992 | CA2087268A1 Assay, methods and products based on nk+ channel expression |
| 01/25/1992 | WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 01/25/1992 | WO1992001419A1 Method of detecting cancer by measuring lipid-peroxidation using nmr |
| 01/25/1992 | CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream |
| 01/25/1992 | CA2087171A1 Method of detecting cancer by measuring lipid-peroxidation using nmr |
| 01/22/1992 | EP0467748A1 Method for detection or dosage of oxygen by EPR spectrometry using lithium phthalocyanine radicals and composition usable for in-vivo dosage |
| 01/22/1992 | EP0467747A1 New crystals of radical lithium phthalocyanine, process for the preparation thereof and their use for "in vivo" determination of molecular oxygen |
| 01/22/1992 | EP0467433A1 Use of a centrally acting ATCH analog in the manufacture of a medicament |
| 01/22/1992 | EP0467337A2 Conservation of diagnostic tests |
| 01/22/1992 | EP0467185A2 Oligomers, their uses and formulations |
| 01/22/1992 | EP0467031A2 Medical-grade lipid-coated microbubbles, paramagnetic labelling thereof and their therapeutic use |
| 01/22/1992 | EP0466816A1 Method for enhancing transmembrane transport of exogenous molecules |
| 01/21/1992 | WO1992001474A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | US5082649 Reducing toxicity |
| 01/21/1992 | CA2087163A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | CA1294610C Fluorescent substance, process for producing thereof and cell-discriminating agent containing the same |
| 01/21/1992 | CA1294545C In vivo cellular tracking |
| 01/21/1992 | CA1294544C Cell growth rate determination |